Vanguard Personalized Indexing Management
AXSM icon

Vanguard Personalized Indexing Management’s Axsome Therapeutics AXSM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$746K Buy
3,047
+79
+3% +$17.1K 0.01% 1163
2026
Q1 		$502K Buy
2,968
+778
+36% +$134K ﹤0.01% 1310
2025
Q4 		$400K Buy
2,190
+89
+4% +$12.4K ﹤0.01% 1367
2025
Q3 		$255K Buy
2,101
+134
+7% +$15.1K ﹤0.01% 1579
2025
Q2 		$205K Buy
+1,967
New +$208K ﹤0.01% 1619

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Personalized Indexing Management's AXSM Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Axsome Therapeutics (AXSM) stake by 2.7% in Q2 2026, buying an estimated $17.1K and bringing the position to 3,047 shares worth $746K. The position accounts for 0.01% of the portfolio, ranked #1163.

Vanguard Personalized Indexing Management first reported a position in AXSM in Q2 2025 and has held it in 5 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Vanguard Personalized Indexing Management held 3,047 shares of Axsome Therapeutics worth $746K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 79 Axsome Therapeutics shares in Q2 2026, an estimated $17.1K.
  • Axsome Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1163 holding.
  • Vanguard Personalized Indexing Management first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.